Cyproconazole

SKU: orb1308414

Description

Cyproconazole

Research Area

Infectious Disease & Virology

Key Properties

• CAS Number: 94361-06-5
• MW: 291.78
• Purity: 98.04% (May vary between batches)
• Formula: C₁₅H₁₈ClN₃O
• SMILES: CC(C1CC1)C(O)(Cn1cncn1)c1ccc(Cl)cc1
• Target: Antibacterial,Antifungal
• Solubility: DMSO:50 mg/mL (171.36 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.85 mM)

Bioactivity

• In Vivo:
  Cyproconazole causes hepatocellular adenomas and carcinomas in CD-1 mice at dose levels of 100 and 200 ppm. In wild-type mice, 200 ppm cyproconazole caused liver hypertrophy, single-cell necrosis, increased liver weight and cell proliferation, and fat vacuolation .
  Read more...
• In Vitro:
  Cyproconazole showed the lowest capacity to increase CYP1A1. Cyproconazole causes a dose dependent inhibition of progesterone production in human placental cells in vitro. However, they were not able to activate the AhR in the transactivation assay .
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

inhibit, Inhibitor, Cyproconazole, Bacterial

Compound Identifiers

PubChem CID

86132